pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    ATI-1013
    Thromboangiitis obliterans (Buerger disease) Antidote Therapeutics Inc
  • Preclinical
    ATI-1701
    Tularaemia Appili Therapeutics Inc
  • Preclinical
    ATLX–0199
    Unspecified Cardiovascular Disorders Atelerix Life Sciences Inc
  • Preclinical
← prev
page 60 of 271
next →
Pain89
Neurology1
ATORM-S
Xerostomia
Organoid Science Co Ltd
  • ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
    ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
    no indication MYLAN
  • Phase 2
    ATR-04
    Skin Rash$AZTR Azitra, Inc.
  • Phase 1
    ATR-12
    Netherton Syndrome (Bamboo Hair)$AZTR Azitra, Inc.
  • Phase 2
    ATRN-119
    Ovarian Cancer$APRE Aprea Therapeutics, Inc.
  • Phase 2
    ATSN-101
    Leber Congenital Amaurosis (LCA) Atsena Therapeutics Inc
  • Phase 3
    ATSN-201
    Unspecified Ophthalmological Disorders Atsena Therapeutics Inc
  • Preclinical
    ATX-101
    T-Cell Lymphomas Abcon Therapeutics Inc
  • Phase 2
    ATX-295
    Ovarian Cancer Accent Therapeutics Inc
  • Phase 1
    AU-409
    Bile Duct Cancer (Cholangiocarcinoma) Auransa Inc
  • AUBAGIO
    AUBAGIO (TERIFLUNOMIDE)
    no indication Sanofi-Aventis US LLC
  • Phase 1
    AUG-801
    Congenital Disorder of Glycosylation AUG Therapeutics LLC
  • AUGMENTIN ES-600
    AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM)
    no indication US ANTIBIOTICS
  • Preclinical
    AUM-302
    Neuroblastoma AUM Biosciences Pte Ltd
  • Phase 1
    AUR-200
    Systemic Lupus Erythematosus$AUPH Aurinia Pharmaceuticals Inc.
  • Phase 1
    AUT-00201
    Myoclonic Seizure Autifony Therapeutics Ltd
  • Phase 1
    AUT-00206
    Fragile X Syndrome Autifony Therapeutics Ltd
  • Phase 2
    AUTO-3
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$AUTL Autolus Therapeutics plc
  • Phase 1
    AUTX-703
    Myelodysplastic Syndrome (Preleukemia) Auron Therapeutics Inc
  • AUVELITY
    AUVELITY (BUPROPION HYDROCHLORIDE)
    1 INDICATIONS AND USAGE AUVELITY is indicated for the tre…$AXSM Axsome Therapeutics, Inc.
  • Phase 2
    AV-0328
    Streptococcal Pneumonia Alopexx Inc
  • Phase 2
    AV-1
    Dengue Fever AbViro LLC
  • Phase 2
    AV-101
    Major Depressive Disorder$VTGN Vistagen Therapeutics, Inc.
  • Phase 1
    AV-1959D
    Alzheimer's Disease Nuravax Inc
  • Phase 1
    AV-203
    Bladder Cancer AVEO Pharmaceuticals Inc
  • Preclinical
    AVA-2206
    Cystinuria Averoa SAS
  • Phase 1
    AVA-6103
    Adenocarcinoma Of The Gastroesophageal Junction Avacta Life Sciences Ltd